These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

569 related items for PubMed ID: 16775503

  • 21. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.
    Béquet F, Uzabiaga F, Desbazeille M, Ludwiczak P, Maftouh M, Picard C, Scatton B, Le Fur G.
    Eur J Neurosci; 2007 Dec; 26(12):3458-64. PubMed ID: 18052990
    [Abstract] [Full Text] [Related]

  • 22. Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure.
    Weis F, Beiras-Fernandez A, Sodian R, Kaczmarek I, Reichart B, Beiras A, Schelling G, Kreth S.
    J Mol Cell Cardiol; 2010 Jun; 48(6):1187-93. PubMed ID: 19931541
    [Abstract] [Full Text] [Related]

  • 23. A study of the mediators involved in the protection induced by exogenous kinins in the isolated rat heart.
    Lagneux C, Adam A, Lamontagne D.
    Int Immunopharmacol; 2003 Oct; 3(10-11):1511-8. PubMed ID: 12946448
    [Abstract] [Full Text] [Related]

  • 24. Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state.
    Rea K, Ford GK, Olango WM, Harhen B, Roche M, Finn DP.
    Eur J Neurosci; 2014 Feb; 39(3):435-43. PubMed ID: 24494683
    [Abstract] [Full Text] [Related]

  • 25. Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide.
    Lagneux C, Lamontagne D.
    Br J Pharmacol; 2001 Feb; 132(4):793-6. PubMed ID: 11181418
    [Abstract] [Full Text] [Related]

  • 26. Effects of endogenous cannabinoid anandamide on excitation-contraction coupling in rat ventricular myocytes.
    Al Kury LT, Voitychuk OI, Ali RM, Galadari S, Yang KH, Howarth FC, Shuba YM, Oz M.
    Cell Calcium; 2014 Feb; 55(2):104-18. PubMed ID: 24472666
    [Abstract] [Full Text] [Related]

  • 27. Prospects for Creation of Cardioprotective Drugs Based on Cannabinoid Receptor Agonists.
    Maslov LN, Khaliulin I, Zhang Y, Krylatov AV, Naryzhnaya NV, Mechoulam R, De Petrocellis L, Downey JM.
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):262-72. PubMed ID: 26487546
    [Abstract] [Full Text] [Related]

  • 28. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
    Nucci C, Gasperi V, Tartaglione R, Cerulli A, Terrinoni A, Bari M, De Simone C, Agrò AF, Morrone LA, Corasaniti MT, Bagetta G, Maccarrone M.
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
    [Abstract] [Full Text] [Related]

  • 29. Bi-directional CB1 receptor-mediated cardiovascular effects of cannabinoids in anaesthetized rats: role of the paraventricular nucleus.
    Grzeda E, Schlicker E, Luczaj W, Harasim E, Baranowska-Kuczko M, Malinowska B.
    J Physiol Pharmacol; 2015 Jun; 66(3):343-53. PubMed ID: 26084216
    [Abstract] [Full Text] [Related]

  • 30. Cannabinoid receptor antagonists and fatty acids alter endocannabinoid system gene expression and COX activity.
    Kim J, Watkins BA.
    J Nutr Biochem; 2014 Aug; 25(8):815-23. PubMed ID: 24854955
    [Abstract] [Full Text] [Related]

  • 31. Cannabinoid CB(1) receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle.
    Baldassano S, Serio R, Mule' F.
    Eur J Pharmacol; 2008 Mar 17; 582(1-3):132-8. PubMed ID: 18234188
    [Abstract] [Full Text] [Related]

  • 32. Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia.
    Muthian S, Rademacher DJ, Roelke CT, Gross GJ, Hillard CJ.
    Neuroscience; 2004 Mar 17; 129(3):743-50. PubMed ID: 15541895
    [Abstract] [Full Text] [Related]

  • 33. Cardioprotective properties of humoral factors released from rat hearts subject to ischemic preconditioning.
    Serejo FC, Rodrigues LF, da Silva Tavares KC, de Carvalho AC, Nascimento JH.
    J Cardiovasc Pharmacol; 2007 Apr 17; 49(4):214-20. PubMed ID: 17438406
    [Abstract] [Full Text] [Related]

  • 34. Possible inhibitory role of endogenous 2-arachidonoylglycerol as an endocannabinoid in (±)-epibatidine-induced activation of central adrenomedullary outflow in the rat.
    Shimizu T, Tanaka K, Shimizu S, Higashi Y, Yawata T, Nakamura K, Taniuchi K, Ueba T, Yuri K, Saito M.
    Neuropharmacology; 2015 Aug 17; 95():278-89. PubMed ID: 25882827
    [Abstract] [Full Text] [Related]

  • 35. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
    White R, Hiley CR.
    Br J Pharmacol; 1997 Dec 17; 122(8):1573-84. PubMed ID: 9422801
    [Abstract] [Full Text] [Related]

  • 36. Probable involvement of Ca(2+)-activated Cl(-) channels (CaCCs) in the activation of CB1 cannabinoid receptors.
    Romero TR, Pacheco Dda F, Duarte ID.
    Life Sci; 2013 May 02; 92(14-16):815-20. PubMed ID: 23123446
    [Abstract] [Full Text] [Related]

  • 37. 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.
    Llorente-Berzal A, Terzian AL, di Marzo V, Micale V, Viveros MP, Wotjak CT.
    Psychopharmacology (Berl); 2015 Aug 02; 232(15):2811-25. PubMed ID: 25814137
    [Abstract] [Full Text] [Related]

  • 38. Blunted cardiac response to hemorrhage in cirrhotic rats is mediated by local macrophage-released endocannabinoids.
    Gaskari SA, Liu H, D'Mello C, Kunos G, Lee SS.
    J Hepatol; 2015 Jun 02; 62(6):1272-7. PubMed ID: 25640062
    [Abstract] [Full Text] [Related]

  • 39. Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid.
    Laine K, Järvinen K, Mechoulam R, Breuer A, Järvinen T.
    Invest Ophthalmol Vis Sci; 2002 Oct 02; 43(10):3216-22. PubMed ID: 12356827
    [Abstract] [Full Text] [Related]

  • 40. Activation of cannabinoid CB1 receptors induces glucose intolerance in rats.
    Bermúdez-Siva FJ, Serrano A, Diaz-Molina FJ, Sánchez Vera I, Juan-Pico P, Nadal A, Fuentes E, Rodríguez de Fonseca F.
    Eur J Pharmacol; 2006 Feb 15; 531(1-3):282-4. PubMed ID: 16423347
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.